Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-24

Clinical Trial Update: Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy [NA]

View source ↗

Summary

A prospective study evaluating whether alpha-blocker therapy improves dysuria and irritative urinary symptoms after HoLEP surgery for benign prostatic hyperplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha-blocker therapy

Snippet

Sponsor: Ankara Training and Research Hospital | Conditions: Prostate Hyperplasia | NA | Status: RECRUITING